Pluri Inc. (PLUR)
NASDAQ: PLUR · Real-Time Price · USD
4.330
-0.340 (-7.28%)
Feb 21, 2025, 4:00 PM EST - Market closed
Pluri Revenue
Pluri had revenue of $185.00K in the quarter ending December 31, 2024, with 76.19% growth. This brings the company's revenue in the last twelve months to $678.00K, up 89.92% year-over-year. In the fiscal year ending June 30, 2024, Pluri had annual revenue of $326.00K with 13.59% growth.
Revenue (ttm)
$678.00K
Revenue Growth
+89.92%
P/S Ratio
34.51
Revenue / Employee
$5,746
Employees
118
Market Cap
30.30M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
PLUR News
- 4 days ago - Ever After Foods and Bühler Collaborate to Scale Cultivated Meat Production and Distribution - GlobeNewsWire
- 4 weeks ago - Pluri Secures $6.5 Million Strategic Investment at Premium to Market, Enters Cacao Market Through Acquisition - GlobeNewsWire
- 2 months ago - Pluri Congratulates Mesoblast on FDA Approval of First Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease - GlobeNewsWire
- 3 months ago - Pluri Inc. to Present at November 21st Virtual Investor Summit Microcap Event - Accesswire
- 3 months ago - BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn® Phase 3b Trial Manufacturing - PRNewsWire
- 7 months ago - Pluri's CDMO Selected to Manufacture Kadimastem's Novel Cell Therapy Product Candidates - GlobeNewsWire
- 8 months ago - Pluri: Biotech Play With Several Opportunities Across Different Sectors - Seeking Alpha
- 8 months ago - Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges - GlobeNewsWire